Morgan Stanley’s Tuscan Holdings Corp. II Common Stock THCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,000
Closed -$10K 8098
2022
Q2
$10K Sell
1,000
-1,077
-52% -$11.5K ﹤0.01% 7224
2022
Q1
$23K Sell
2,077
-4,000
-66% -$41K ﹤0.01% 7100
2021
Q4
$62K Sell
6,077
-150
-2% -$1.52K ﹤0.01% 6712
2021
Q3
$63K Sell
6,227
-3,106
-33% -$31.2K ﹤0.01% 6614
2021
Q2
$94K Sell
9,333
-16,112
-63% -$162K ﹤0.01% 6394
2021
Q1
$257K Buy
25,445
+3,517
+16% +$37.4K ﹤0.01% 5509
2020
Q4
$241K Buy
+21,928
New +$227K ﹤0.01% 5500
2020
Q3
Sell
-212
Closed -$2K 6894
2020
Q2
$2K Sell
212
-114
-35% -$1.13K ﹤0.01% 6480
2020
Q1
$3K Sell
326
-599
-65% -$5.91K ﹤0.01% 6351
2019
Q4
$9K Buy
+925
New +$9.07K ﹤0.01% 6296

Other funds holding THCA

Morgan Stanley's THCA Position: Q3 2022 in Review

Morgan Stanley sold out of Tuscan Holdings Corp. II Common Stock (THCA) in Q3 2022, closing a stake of 1,000 shares — an estimated $10K sold.

Morgan Stanley first reported a position in THCA in Q4 2019 and held it in 10 quarters. The position peaked at $257K in Q1 2021. 16 funds tracked by Wall St. Rank hold THCA as of Q3 2022.

  • Morgan Stanley reported no remaining Tuscan Holdings Corp. II Common Stock position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 1,000 Tuscan Holdings Corp. II Common Stock shares in Q3 2022, an estimated $10K.
  • Morgan Stanley first reported a position in Tuscan Holdings Corp. II Common Stock in Q4 2019 and held it in 10 quarters.
  • Morgan Stanley's Tuscan Holdings Corp. II Common Stock position peaked at $257K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Tuscan Holdings Corp. II Common Stock as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.